title: Effects of 8 h of isocapnic hypoxia with and without muscarinic blockade on ventilation and heart rate in humans.
abstract: This study examined the role of muscarinic parasympathetic mechanisms in generating the progressive increases in ventilation (V(E)) and heart rate previously reported with 8 h exposures to hypoxia. The sensitivities of V(E) (G(p)) and heart rate (G(HR)) to acute variations in hypoxia, and V(E) and heart rate during acute hyperoxia were assessed in 10 subjects before and after two 8 h exposures to isocapnic hypoxia (end-tidal P(O2) = 50 mmHg). The responses were measured during muscarinic blockade with glycopyrrolate (0.015 mg kg(-1)) and without glycopyrrolate, as a control. There were significant increases in G(p) (P < 0.01) and V(E) during hyperoxia (P < 0.01) following hypoxic exposure, but these were unaffected by glycopyrrolate. G(HR) increased significantly by 0.29 +/- 0.08 beats min(-1) %(-1) (mean +/- S.E.M.) following exposure to hypoxia under control conditions, but only non-significantly by 0.10 +/- 0.08 beats min(-1) %(-1) with glycopyrrolate. This difference was significant. Changes in heart rate during hyperoxia were slight and inconclusive. We conclude that muscarinic mechanisms play little role in the progressive ventilatory changes that occur over 8 h of hypoxia, but that they do mediate much of the progressive increase in heart rate. Experimental Physiology (2001) 86.4, 529-538.
authors.affiliation: University Laboratory of Physiology, University of Oxford, Parks Road, Oxford, OX1 3PT, UK.
authors.forename: C
authors.initials: C
authors.lastname: Clar
authors.forename: K L
authors.initials: KL
authors.lastname: Dorrington
authors.forename: M
authors.initials: M
authors.lastname: Fatemian
authors.forename: P A
authors.initials: PA
authors.lastname: Robbins
mesh_terms: D000328:Adult; D002245:Carbon Dioxide / Q000097:blood*; D005260:Female; D006024:Glycopyrrolate / Q000008:administration & dosage; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D000860:Hypoxia / Q000503:physiopathology*; D008297:Male; D018727:Muscarinic Antagonists / Q000008:administration & dosage; D010275:Parasympathetic Nervous System / Q000502:physiology; D012119:Respiration
chemical_list: D018727:Muscarinic Antagonists; D002245:Carbon Dioxide; D006024:Glycopyrrolate